Manufacture of pharmaceutical preparations
PROPHYLIX AS
Operating profit
NOK −311,000
Equity
NOK −13.2m
Incorporated
2017
Share capital
NOK 200,000
Key figures · 2024
Current ratio
1.07
Equity ratio
-1469.7%
Key figures over time · 2024
| Key figures | 2024 | Trend |
|---|---|---|
| Lønnsomhet | ||
| Return on assets (%%) | -34.5% | |
| Likviditet | ||
| Current ratio | 1.07 | |
| Working capital | 63k | |
| Soliditet | ||
| Equity ratio (%%) | -1469.7% | |
| Debt-to-equity ratio | -1.07 | |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.